Featured Post
Incidence of pulmonary tuberculosis under the regular COVID-19 epidemic prevention and control in China - BMC Infectious Diseases - BMC Infectious Diseases
World Health Organization (WHO). Global Tuberculosis Report, 2019. https://www.who.int/tb/publications/global_report/en/. Accessed Mar 2021.
Banuls AL, Sanou A, Van Anh NT, Godreuil S. Mycobacterium tuberculosis: ecology and evolution of a human bacterium. J Med Microbiol. 2015;64(11):1261–9.
CAS Article Google Scholar
Dye C, Hosseini M, Watt C. Did we reach the 2005 targets for tuberculosis control? Bull World Health Organ. 2007;85(5):364–9.
Article Google Scholar
Glaziou P, Floyd K, Korenromp EL, Sismanidis C, Bierrenbach AL, Williams BG, et al. Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ. 2011;89(8):573–82.
Article Google Scholar
Mandal S, Chadha VK, Laxminarayan R, Arinaminpathy N. Counting the lives saved by DOTS in India: a model-based approach. BMC Med. 2017;15(1):47.
Article Google Scholar
Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, et al. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet. 2015;386(10010):2344–53.
Article Google Scholar
World Health Organization (WHO). Geneva: World Health Organization, 2012. https://www.ncbi.nlm.nih.gov/pubmed/24404639. Accessed Mar 2021.
Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new End TB Strategy. Lancet. 2015;385(9979):1799–801.
Article Google Scholar
Gong W, Liang Y, Wu X. The current status, challenges, and future developments of new tuberculosis vaccines. Hum Vaccin Immunother. 2018;14(7):1697–716.
Article Google Scholar
Lin HH, Wang L, Zhang H, Ruan Y, Chin DP, Dye C. Tuberculosis control in China: use of modelling to develop targets and policies. Bull World Health Organ. 2015;93(11):790–8.
Article Google Scholar
Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Global Health. 2016;4(11):e806–15.
Article Google Scholar
Huynh GH, Klein DJ, Chin DP, Wagner BG, Eckhoff PA, Liu R, et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med. 2015;13:88.
Article Google Scholar
Xu K, Ding C, Mangan CJ, Li Y, Ren J, Yang S, et al. Tuberculosis in China: a longitudinal predictive model of the general population and recommendations for achieving WHO goals. Respirology. 2017;22(7):1423–9.
Article Google Scholar
Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, et al. Prospects for tuberculosis elimination in the United States: results of a transmission dynamic model. Am J Epidemiol. 2018;187(9):2011–20.
Article Google Scholar
Dockrell HM, Smith SG. What have we learnt about BCG vaccination in the Last 20 years? Front Immunol. 2017;8:1134.
Article Google Scholar
Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. Lancet Respir Med. 2018;6(4):299–314.
Article Google Scholar
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
CAS Article Google Scholar
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.
CAS Article Google Scholar
World Health Organization (WHO). WHO Coronavirus Disease (COVID-19), 2020. https://covid19.who.int/. Accessed Mar 2021.
Yang Z, Zeng Z, Wang K, Wong SS, Liang W, Zanin M, et al. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis. 2020;12(3):165–74.
Article Google Scholar
The National Statutory Infectious Disease Report Statistics Table. The National Statutory Infectious Disease Report Statistics Table, 2020. http://www.nhc.gov.cn/jkj/pqt/new_list.shtml. Accessed Jan 2022.
The National Bureau of Statistics. The total population data, 2020. http://data.stats.gov.cn/easyquery.htm?cn=C01. Accessed Jan 2022.
Kam HJ, Sung JO, Park RW. Prediction of daily patient numbers for a regional emergency medical center using time series analysis. Healthc Inform Res. 2010;16(3):158–65.
Article Google Scholar
Helfenstein U. Box-Jenkins modelling in medical research. Stat Methods Med Res. 1996;5(1):3–22.
CAS Article Google Scholar
Ginestet C. Model Selection and Model Averaging. J R Stat Soc Ser A. 2010;172:937–937.
Article Google Scholar
Liu Q, Liu X, Jiang B, Yang W. Forecasting incidence of hemorrhagic fever with renal syndrome in China using ARIMA model. BMC Infect Dis. 2011;11:218.
Article Google Scholar
Wang T, Liu J, Zhou Y, Cui F, Huang Z, Wang L, et al. Prevalence of hemorrhagic fever with renal syndrome in Yiyuan County, China, 2005–2014. BMC Infect Dis. 2016;16:69.
Article Google Scholar
Zhou L, Zhao P, Wu D, Cheng C, Huang H. Time series model for forecasting the number of new admission inpatients. BMC Med Inform Decis Mak. 2018;18(1):39.
Article Google Scholar
Zhao C, Yang Y, Wu S, Wu W, Xue H, An K, et al. Search trends and prediction of human brucellosis using Baidu index data from 2011 to 2018 in China. Sci Rep. 2020;10(1):5896.
CAS Article Google Scholar
Liu Q, Li Z, Ji Y, Martinez L, Zia UH, Javaid A, et al. Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses. Infect Drug Resist. 2019;12:2311–22.
Article Google Scholar
Box GEP, Tiao GC. Intervention analysis with applications to economic and environmental problems. J Am Stat Assoc. 1975;70(349):70–9.
Article Google Scholar
World Health Organization (WHO). Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief, 2020. https://apps.who.int/iris/handle/10665/333114. Accessed Mar 2021.
Ye Q, Wang B, Mao J, Fu J, Shang S, Shu Q, et al. Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol. 2020;92(7):755–69.
CAS Article Google Scholar
Lönnroth K, Corbett E, Golub J, Godfrey-Faussett P, Uplekar M, Weil D, et al. Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis. 2013;17(3):289–98.
Article Google Scholar
Yang Q, Wang J, Ma H, Wang X. Research on COVID-19 based on ARIMA model(Delta)-Taking Hubei, China as an example to see the epidemic in Italy. J Infect Public Health. 2020;13(10):1415–8.
Article Google Scholar
Wang YW, Shen ZZ, Jiang Y. Comparison of ARIMA and GM(1,1) models for prediction of hepatitis B in China. PLoS ONE. 2018;13(9): e0201987.
Article Google Scholar
Cilloni L, Fu H, Vesga JF, Dowdy D, Pretorius C, Ahmedov S, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020;28: 100603.
Article Google Scholar
Bardhan M, Hasan MM, Ray I, Sarkar A, Chahal P, Rackimuthu S, et al. Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward. Trop Med Health. 2021;49(1):84.
Article Google Scholar
Zong Z, Huo F, Shi J, Jing W, Ma Y, Liang Q, et al. Relapse versus reinfection of recurrent tuberculosis patients in a national tuberculosis specialized hospital in Beijing, China. Front Microbiol. 2018;9:1858.
Article Google Scholar
Shen G, Xue Z, Shen X, Sun B, Gui X, Shen M, et al. The study recurrent tuberculosis and exogenous reinfection, Shanghai, China. Emerg Infect Dis. 2006;12(11):1776–8.
Article Google Scholar
Comments
Post a Comment